Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues

Jan.22
Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
2Firsts reporting shows that, as the European Union moves toward a future evaluation of its tobacco legislation, the Tobacco Policy Expert Group—long a key platform for coordination among Member States—formally concluded its mandate at the end of 2025. At the same time, the European Commission is exploring new cooperation structures to address the resulting institutional gap.

Key Points

 

  • The EU’s Tobacco Policy Expert Group formally concluded its mandate at the end of 2025, with successor arrangements yet to be clarified.
  • The European Commission has confirmed that the evaluation of tobacco legislation is ongoing and that plans for a future revision remain on track.
  • Pending new structures, coordination among Member States continues through existing channels, including the JA-SAFE mechanism.

 


 

2Firsts, January 22, 2026, Brussels —

 

The European Union’s tobacco and nicotine regulatory framework is entering a period of institutional transition, as a long-standing expert advisory body concludes its mandate while the European Commission continues evaluating future legislative changes.

 

A review of publicly available European Commission documents by 2Firsts shows that the Group of Experts on Tobacco Policy (E03150) held its final meeting on October 28, 2025, in Luxembourg. The meeting minutes, published on the Commission’s expert group register on January 5, 2026, confirm that it was the last session under the group’s current mandate.

 

Exclusive | EU Confirms End of Tobacco Policy Expert Group, Explores New Cooperation Structures as TPD Revision Continues
Minutes of the final meeting of the EU Group of Experts on Tobacco Policy (28 October 2025, Luxembourg).| Source: European Commission, DG SANTE (Ref. Ares(2026)28575)

 

Established in 2014 under Commission Decision C(2014) 3509, the expert group served as a formal forum for cooperation and information exchange between the Commission and Member States on tobacco control. Its remit included supporting the preparation and implementation of EU tobacco legislation, including delegated acts under the Tobacco Products Directive (TPD).

 

Although the group continues to appear as “active” in the Commission’s register, its legal basis expired at the end of 2025. According to the October meeting minutes, no further meetings were scheduled, and no successor expert group has so far been publicly announced.

 

Transition after the expert group

 

According to the meeting minutes, the Commission is exploring future structures for cooperation and information exchange with Member States following the conclusion of the expert group’s mandate. At the same time, engagement with national authorities on tobacco and nicotine control is continuing through existing, file-specific channels.

 

The approach points to an effort to preserve policy continuity while reassessing how technical coordination and consultation are organised at EU level, particularly as regulatory debates around novel tobacco and nicotine products continue to evolve.

 

TPD evaluation remains underway

 

The end of the expert group does not signal a pause in EU tobacco legislation. The October meeting minutes show that the Commission continues to carry out a comprehensive evaluation of both the Tobacco Products Directive (Directive 2014/40/EU) and the Tobacco Advertising Directive, with Member States encouraged to submit data, experience and feedback to inform the process.

 

Commission documentation further shows that the Commission intends to bring forward a revision of the legislative framework on tobacco control once the evaluation phase is completed. No formal proposal has yet been tabled, and no official timeline has been confirmed.

 

The ongoing work on tobacco regulation has been linked to broader public health initiatives. At the October meeting, the chair referred to the EU Cardiovascular Health Plan, highlighting the close relationship between tobacco use and cardiovascular disease prevention.

 

Cardiovascular Health Plan draws attention

 

As previously reported by 2Firsts in September 2025, the European Commission’s public consultation on the EU Cardiovascular Health Plan — a non-legislative Commission Communication led by DG SANTE — had already drawn attention from stakeholders concerned about how cardiovascular prevention narratives might influence future tobacco legislation.

 

Although the consultation documents do not explicitly mention nicotine, stakeholder submissions revealed a clear divide. Harm reduction advocates called for evidence-based, risk-proportionate regulation recognising the lower risks of non-combustible products, while restriction-focused organisations urged stricter controls, including flavour bans and the equal treatment of all nicotine products.

 

The plan, which the Commission had previously indicated was targeting adoption in late 2025, continues to be closely watched, as any references to prevention and unhealthy behaviours could later be cited in debates surrounding a future revision of the TPD.

 

Role of JA-SAFE and internal responsibilities

 

Alongside legislative evaluation, the Commission continues to advance implementation-focused initiatives. One such project is JA-SAFE — the Joint Action on Health Promotion and Disease Prevention, including Smoke- and Aerosol-Free Environments — which was presented to Member States at the October meeting.

 

JA-SAFE is designed to support the implementation of the Council Recommendation on smoke-free and aerosol-free environments, primarily through cooperation, pilot activities, data sharing and the dissemination of best practices. It functions as a complementary, execution-oriented framework rather than a policy-shaping or legislative body.

 

Within the Commission, responsibility for tobacco control remains assigned to Directorate C of the Directorate-General for Health and Food Safety (DG SANTE), in line with established internal governance arrangements. The allocation reflects administrative organisation rather than a shift in policy direction.

 

A period of adjustment

 

Taken together, the publicly available documents suggest that EU tobacco and nicotine policy is entering a transitional phase. The conclusion of the expert group closes a formal chapter in Member State coordination, while evaluation work and preparatory steps for possible legislative revision continue within the Commission.

 

How future cooperation structures will be designed — and how they will interact with broader public health strategies such as the Cardiovascular Health Plan — remains to be seen. What is clear is that the regulatory debate over tobacco harm reduction, novel products and risk-differentiated policy is far from settled.

 

For further updates on European tobacco and nicotine regulatory developments, stay tuned to 2Firsts’ ongoing coverage.

 

Cover image:The European Quarter in Brussels.| Source: Photo by 2Firsts


 

Further reading:

 

2FIRSTS | Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
2FIRSTS | Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
www.2firsts.com

2FIRSTS | Special Report | Battle Over Flavors: Spain’s flavor and pouch curbs spark Brussels showdown over the single market
2FIRSTS | Special Report | Battle Over Flavors: Spain’s flavor and pouch curbs spark Brussels showdown over the single market
Spain’s proposed ban on non-tobacco vape flavors and strict cap on nicotine pouches has evolved from a domestic tobacco control measure into a major dispute at the EU level. This report traces the full trajectory of the controversy—covering policy background, EU review, stakeholder positions, and potential impacts—showing how the debate has moved beyond tobacco control to challenge the fundamental freedoms of the EU single market.
www.2firsts.com

JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
Japan’s Heated Tobacco Tax Changes Reshape Consumer Choices, Survey Reveals Impact of Price and Income
Japan’s Heated Tobacco Tax Changes Reshape Consumer Choices, Survey Reveals Impact of Price and Income
A consumer survey by Japanese heated tobacco information platform RELAZO found that rising tobacco prices and planned heated tobacco tax changes may influence smoking decisions among Japanese consumers. The survey covered 49,879 men and women aged 20 to 69 nationwide. It found that around 40% of respondents cumulatively indicated they may consider quitting when a pack reaches ¥600 (approximately US$4.1), while nearly 90% expressed potential quitting intentions at a ¥1,000 (approximately US$6.8) price level. The survey also found significant differences by income level, with lower-income respondents showing greater sensitivity to price increases.
Jul.24
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04